Clinical Trial Update: Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of AZD1981, a CRTh2 antagonist, in chronic idiopathic urticaria; the study is completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Urticaria

Drugs mentioned

• AZD1981

Snippet

Sponsor: Johns Hopkins University | Conditions: Chronic Idiopathic Urticaria | Phase 2 | Status: COMPLETED | Results posted: 2017-07-12